Choksi Laboratories Ltd
BSE:526546
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
41.46
88.25
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Choksi Laboratories Ltd
Other Liabilities
Choksi Laboratories Ltd
Other Liabilities Peer Comparison
REPL
RITES
LATENTVIEW
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
C
|
Choksi Laboratories Ltd
BSE:526546
|
Other Liabilities
₹18.2m
|
CAGR 3-Years
19%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
L
|
L&T Technology Services Ltd
NSE:LTTS
|
Other Liabilities
₹96m
|
CAGR 3-Years
-73%
|
CAGR 5-Years
-51%
|
CAGR 10-Years
N/A
|
|
|
Rudrabhishek Enterprises Ltd
NSE:REPL
|
Other Liabilities
₹10.3m
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
e
|
eMudhra Ltd
NSE:EMUDHRA
|
Other Liabilities
₹54.5m
|
CAGR 3-Years
5%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
RITES Ltd
NSE:RITES
|
Other Liabilities
₹2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Latent View Analytics Ltd
NSE:LATENTVIEW
|
Other Liabilities
₹93.9m
|
CAGR 3-Years
41%
|
CAGR 5-Years
35%
|
CAGR 10-Years
N/A
|
See Also
What is Choksi Laboratories Ltd's Other Liabilities?
Other Liabilities
18.2m
INR
Based on the financial report for Mar 31, 2024, Choksi Laboratories Ltd's Other Liabilities amounts to 18.2m INR.
What is Choksi Laboratories Ltd's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
-12%
Over the last year, the Other Liabilities growth was 19%. The average annual Other Liabilities growth rates for Choksi Laboratories Ltd have been 19% over the past three years , -12% over the past five years .
You don't have any saved screeners yet
